Business
MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX
MRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX.
About this update from Institute Of Biomedical Research Corp.
[{"type":"text","content":"\n\n\n\nMRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMRES: M2Bio Sciences Enters into Letter of Intent to Acquire Crypto Exchange JDAX\nPR Newswire\nCAPE TOWN, South Africa, June 27, 2023\n\n\n\nCAPE TOWN, South Africa, June 27, 2023 /PRNewswire/ -- Institute of Biomedical Research Corp. (OTC PINK: MRES) (\"Institute of Biomedical Research\" or the \"Company\"), a nutraceutical biotechnology company focused on alternative plant-based cannabinoids, medical psilocybin and mental health therapeutic research powered by artificial intelligence, and evidence-based sustainable products and solutions, is pleased to share the following update:\nM2Bio Sciences is thrilled to announce the signing of a letter of intent to acquire JDAX, a major cryptocurrency platform facilitating seamless exchange, trading, and secure storage of digital currencies.\nFunctioning as a cutting-edge digital marketplace, JDAX empowers users to buy, sell, and hold a wide range of cryptocurrencies. Moreover, it facilitates essential activities such as managing digital wallets, executing trades, and accessing comprehensive market data.\nJDAX, the Johannesburg Digital Assets Exchange, represents a notable South African Fintech company immersed in the realms of Blockchain, Web3, and Decentralized Finance (DeFi) technologies. By positioning itself at the forefront of these advancements, M2Bio aims to accelerate the traditionally challenging and time-consuming process of natural product drug discovery. Through collaborations with prestigious universities and the support of multiple funded research chairs, the M2Bio Research Team is engaged in the extraction of bioactive compounds from an extensive collection of African plants renowned for their potential efficacy. Leveraging novel extraction methods and AI models, M2Bio exponentially enhances the pace of discovery and characterization of potentially bioactive compounds.\nAt this opportune moment, M2Bio aligns itself with the rapid progress of AI and its broad applicat...